COVID-19 Biotech Companies on Stock Exchange (2020)

Tags: The coronavirus pandemic has affected the entire world and many families have been destroyed. The stock exchange was also affected, but vaccine companies took advantage of this moment and leveraged their profits.

Biotech companies:

Pfizer develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including infectious diseases, oncology, and rare diseases.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, primarily for the treatment of cardiovascular, renal, and metabolic diseases, as well as oncology and respiratory diseases.

BioNTech is a biotechnology company that develops and commercializes immunotherapies for cancer and other infectious diseases. Its product pipeline includes various candidates in different stages of development, including mRNA-based vaccines and therapies.

Moderna is a clinical-stage biotechnology company that develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. Its product pipeline includes various candidates in different stages of development, including mRNA-based vaccines and therapies.

Novavax is a late-stage biotechnology company that focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its product pipeline includes various candidates in different stages of development, including vaccines for COVID-19, influenza, and other infectious diseases.

Companies: Pfizer, AstraZeneca, BioNTech, Moderna, Novavax

Keywords: COVID-19, biotech companies, stock exchange, vaccine development, infectious diseases, immunotherapy, messenger RNA, pandemic.